Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Modern Pharmaceutical Preparation Engineering Research Center is a specialized research and development organization focused on advanced drug delivery systems and pharmaceutical formulation engineering. Established in 1996 as a national-level engineering center, it operates as a key subsidiary of Sinopharm Modern Pharmaceutical. The center excels in the development of complex dosage forms, including sustained-release, controlled-release, and targeted delivery systems for small molecule drugs. It provides comprehensive technical services such as formulation optimization, process scale-up, and technology transfer to the broader pharmaceutical industry. By bridging the gap between laboratory innovation and industrial-scale manufacturing, the center plays a vital role in the commercialization of high-quality generic and improved therapeutic products. Its expertise spans multiple therapeutic areas, including cardiovascular health, infectious diseases, and metabolic disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Modern Pharmaceutical Preparation Engineering Research Center.